The Drug Testing Company Limited

The Drug Testing Company Limited, a registered company, was started on 09 Jan 2015. 9429041562123 is the NZ business identifier it was issued. "Testing or assay service" (ANZSIC M692550) is how the company was classified. The company has been managed by 4 directors: Benjamin Allen - an active director whose contract started on 26 Jun 2015,
John Nicholas Wyatt - an active director whose contract started on 26 Jun 2015,
Brett Bothma - an active director whose contract started on 26 Jun 2015,
Philip Mortimer O'brien - an inactive director whose contract started on 09 Jan 2015 and was terminated on 29 Jun 2015.
Updated on 06 Apr 2024, BizDb's data contains detailed information about 1 address: Level 1, 3 Lorne Street, Auckland Cbd, Auckland, 1010 (types include: registered, registered).
The Drug Testing Company Limited had been using Level 3, 104 The Terrace, Wellington as their registered address up until 18 Nov 2020.
A total of 1200 shares are allocated to 6 shareholders (3 groups). The first group is comprised of 400 shares (33.33%) held by 1 entity. There is also a second group which includes 3 shareholders in control of 400 shares (33.33%). Finally the third share allocation (400 shares 33.33%) made up of 2 entities.

Previous addresses

Address #1: Level 3, 104 The Terrace, Wellington, 6011 New Zealand

Registered & physical address used from 18 Feb 2019 to 18 Nov 2020

Address #2: 104 The Terrace, Wellington Central, Wellington, 6011 New Zealand

Physical & registered address used from 09 Jan 2015 to 18 Feb 2019

Previous Shareholders

Benjamin Allen - Director

Appointment date: 26 Jun 2015

John Nicholas Wyatt - Director

Appointment date: 26 Jun 2015

Brett Bothma - Director

Appointment date: 26 Jun 2015

Philip Mortimer O'brien - Director (Inactive)

Appointment date: 09 Jan 2015

Termination date: 29 Jun 2015